This program supports members at every stage of their journeywhether theyre navigating menopause, using GLP-1 weight-loss medications, or simply looking to build sustainable movement into a healthier lifestyle
doi: 10.3389/fimmu.2026.1744308 Received 11 November 2025 Revised 04 April 2026 Accepted 13 April 2026 Published 28 April 2026 Volume 17 - 2026 Edited by Francesco Caso, University of Naples Federico II, Italy Reviewed by Piero Ruscitti, University of LAquila, Italy Silvia Scriffignano, Fondazione Istituto G.Giglio, Italy Updates Copyright 2026 Ciancio, Maranini, Sandri, Amati, Bortoluzzi, Silvagni, Govoni and Giuggioli
Raun K, et al
If nausea occurs, reduce the dose temporarily
Blood AST, ALT and urea/BUN level analysis
Summary of product characteristics (afamelanotide/Scenesse)